Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CNS · NYSE · Asset Management & Custody Banks
$63.93−0.89 (−1.37%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Cohen & Steers, Inc. (CNS) · oqro.io/stocks/CNS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Planned sale · Planned for Nov 19, 2026 · Notice filed Nov 19, 2026
Officer filed to sell about $133K of CNS stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Segall Bryant & Hamill, LLC disclosed a new position in CNS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 4, 2026
Copeland Capital Management, LLC disclosed a reduced position in CNS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 24, 2026
Boston Trust Walden Corp disclosed a reduced position in CNS for Q2 2026SourceInsider trade · Traded Jul 20, 2026 · Filed Jul 21, 2026
Officer sold ~$91K of CNS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 10, 2026
Wasatch Advisors LP disclosed a reduced position in CNS for Q2 2026SourceInsider trade · Traded Jun 16, 2026 · Filed Jun 16, 2026
Officer sold ~$337K of CNS shares in the open marketSourceInsider trade · Traded May 26, 2026 · Filed May 27, 2026
Officer sold ~$753K of CNS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 24, 2026
Boston Trust Walden Corp disclosed a reduced position in CNS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 21, 2026
Wasatch Advisors LP disclosed an increased position in CNS for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
BAMCO Inc disclosed a reduced position in CNS for Q4 2025SourceInsider trade · Traded Feb 12, 2026 · Filed Feb 12, 2026
Officer sold ~$657K of CNS shares in the open marketSourceInsider trade · Traded Feb 11, 2026 · Filed Feb 12, 2026
Officer sold ~$330K of CNS shares in the open marketSourceInsider trade · Traded Feb 11, 2026 · Filed Feb 12, 2026
Officer sold ~$306K of CNS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 29, 2026
Copeland Capital Management, LLC disclosed a reduced position in CNS for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 28, 2026
Boston Trust Walden Corp disclosed a reduced position in CNS for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 9, 2026
Congress Asset Management Co disclosed a reduced position in CNS for Q4 2025SourceInsider trade · Traded Nov 18, 2025 · Filed Nov 20, 2025
Director purchased ~$2.98M of CNS shares in the open marketSourceInsider trade · Traded Nov 19, 2025 · Filed Nov 20, 2025
Chair purchased ~$1.14M of CNS shares in the open marketSourceInsider trade · Traded Nov 19, 2025 · Filed Nov 20, 2025
Director purchased ~$1.35M of CNS shares in the open marketSourceInsider trade · Traded Nov 19, 2025 · Filed Nov 20, 2025
Director purchased ~$878K of CNS shares in the open marketSourceInsider trade · Traded Oct 22, 2025 · Filed Oct 22, 2025
Chair purchased ~$464K of CNS shares in the open marketSourceInsider trade · Traded Oct 22, 2025 · Filed Oct 22, 2025
Chair purchased ~$466K of CNS shares in the open marketSourceInsider trade · Traded Oct 20, 2025 · Filed Oct 22, 2025
Chair purchased ~$444K of CNS shares in the open marketSourceInsider trade · Traded Oct 21, 2025 · Filed Oct 22, 2025
Chair purchased ~$396K of CNS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Wasatch Advisors LP disclosed an increased position in CNS for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Jul 28, 2025
Boston Trust Walden Corp disclosed an increased position in CNS for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Jul 21, 2025
Copeland Capital Management, LLC disclosed a reduced position in CNS for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Jul 16, 2025
Congress Asset Management Co disclosed a reduced position in CNS for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Wasatch Advisors LP disclosed an increased position in CNS for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
BAMCO Inc disclosed a reduced position in CNS for Q1 2025SourceInsider trade · Traded May 9, 2025 · Filed May 12, 2025
Officer sold ~$2.04M of CNS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Apr 24, 2025
Copeland Capital Management, LLC disclosed a reduced position in CNS for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Apr 11, 2025
Congress Asset Management Co disclosed an increased position in CNS for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 13, 2025
Wasatch Advisors LP disclosed a reduced position in CNS for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 13, 2025
Gamco Investors, Inc. disclosed a reduced position in CNS for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 10, 2025
Nicholas Company, Inc. disclosed a reduced position in CNS for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Jan 30, 2025
Congress Asset Management Co disclosed an increased position in CNS for Q4 2024SourceInsider trade · Traded Dec 2, 2024 · Filed Dec 3, 2024
Officer sold ~$702K of CNS shares in the open marketSourceInsider trade · Traded Dec 2, 2024 · Filed Dec 3, 2024
Officer sold ~$10K of CNS shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Wasatch Advisors LP disclosed a reduced position in CNS for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
BAMCO Inc disclosed a reduced position in CNS for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Gamco Investors, Inc. disclosed a reduced position in CNS for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Oct 28, 2024
Congress Asset Management Co disclosed an increased position in CNS for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Oct 24, 2024
Boston Trust Walden Corp disclosed a reduced position in CNS for Q3 2024SourceInsider trade · Traded Oct 18, 2024 · Filed Oct 22, 2024
Director sold ~$160K of CNS shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 22, 2024
Director sold ~$104K of CNS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 12, 2026
Wasatch Advisors LP disclosed a reduced position in CNS for Q4 2025SourceInsider trade · Traded Nov 20, 2025 · Filed Nov 20, 2025
Director purchased ~$773K of CNS shares in the open marketSourceInsider trade · Traded Nov 19, 2025 · Filed Nov 20, 2025
Chair purchased ~$359K of CNS shares in the open marketSourcePolitician trade (House) · Transaction Oct 30, 2025 · Disclosed Nov 18, 2025
Disclosed purchase of CNS — reported range $1,001 - $15,000SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Wasatch Advisors LP disclosed a reduced position in CNS for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
BAMCO Inc disclosed a reduced position in CNS for Q3 2025SourceInsider trade · Traded Nov 4, 2025 · Filed Nov 5, 2025
Chair purchased ~$1.85M of CNS shares in the open marketSourceInsider trade · Traded Nov 3, 2025 · Filed Nov 5, 2025
Chair purchased ~$1.35M of CNS shares in the open marketSourceInsider trade · Traded Nov 5, 2025 · Filed Nov 5, 2025
Chair purchased ~$1.31M of CNS shares in the open marketSourceInsider trade · Traded Nov 3, 2025 · Filed Nov 5, 2025
Chair purchased ~$1.17M of CNS shares in the open marketSourceInsider trade · Traded Nov 4, 2025 · Filed Nov 5, 2025
Chair purchased ~$1.02M of CNS shares in the open marketSourceInsider trade · Traded Nov 3, 2025 · Filed Nov 5, 2025
Chair purchased ~$89K of CNS shares in the open marketSourceInsider trade · Traded Nov 4, 2025 · Filed Nov 5, 2025
Chair purchased ~$44K of CNS shares in the open marketSourceInsider trade · Traded Nov 3, 2025 · Filed Nov 5, 2025
Chair purchased ~$21K of CNS shares in the open marketSourceInsider trade · Traded Oct 21, 2025 · Filed Oct 22, 2025
Chair purchased ~$387K of CNS shares in the open marketSourceInsider trade · Traded Oct 20, 2025 · Filed Oct 22, 2025
Chair purchased ~$361K of CNS shares in the open marketSourceInsider trade · Traded Oct 22, 2025 · Filed Oct 22, 2025
Chair purchased ~$142K of CNS shares in the open marketSourceInsider trade · Traded Oct 22, 2025 · Filed Oct 22, 2025
Chair purchased ~$137K of CNS shares in the open marketSourceInsider trade · Traded Oct 20, 2025 · Filed Oct 22, 2025
Chair purchased ~$36K of CNS shares in the open marketSourceInsider trade · Traded Oct 20, 2025 · Filed Oct 22, 2025
Chair purchased ~$12K of CNS shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 17, 2025
Copeland Capital Management, LLC disclosed a reduced position in CNS for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 17, 2025
Boston Trust Walden Corp disclosed a reduced position in CNS for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 10, 2025
Congress Asset Management Co disclosed an increased position in CNS for Q3 2025SourcePolitician trade (House) · Transaction Sep 25, 2024 · Disclosed Oct 3, 2024
Disclosed partial sale of CNS — reported range $1,001 - $15,000Source